Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-43072
Dev Dyn. June 1, 2011; 240 (6): 1467-74.

New doxycycline-inducible transgenic lines in Xenopus.



Abstract
We have characterized two new transgenic Xenopus lines enabling transgene expression using the Tet-On inducible system. An inducer line expresses the doxycycline- (Dox-) activated transcription factor rtTA under control of the ubiquitous promoter CMV. A responder line enables Dox-inducible expression of a dominant positive thyroid hormone receptor via a tetracycline responsive transgenic promoter (TRE). Dox-induced expression of transgenic GFP mRNA was detectable after 3 hr and increased up to 10- to 50-fold by 2 days depending on dose of Dox. Induced GFP mRNA expression returned to uninduced levels within 3 days upon Dox removal. Treatment of rtTA inducer and TRE responder double transgenic animals with Dox caused acceleration of metamorphic changes in thyroid hormone-response gene expression and morphology. These transgenic lines will be made available through the new Xenopus Stock Center and will serve as valuable tools for genetic analysis of development and metamorphosis.

PubMed ID: 21491543
PMC ID: PMC3092863
Article link: Dev Dyn.
Grant support: R01 DK070858 NIDDK NIH HHS , R03 5F32DK010069-03 NIDDK NIH HHS , R03 HD059995 NICHD NIH HHS , R03 HD059995-01 NICHD NIH HHS , R01 DK070858-04 NIDDK NIH HHS , R01 DK070858-05 NIDDK NIH HHS

Genes referenced: rpl8 thrsp
Antibodies referenced:
Article Images: [+] show captions

My Xenbase: [ Log-in / Register ]
version: [3.2.2]


Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556